Nurix Therapeutics, Inc. ($NRIX)
Filing Information
| Accession Number | 0001817217-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 31, 2026 |
| Document Date | Jan 30, 2026 |
| Document | View SEC Filing |
Transactions
10
Total Shares
26,653
Total Value
$60,766.50
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Jan 30, 2026 | Exercise/Conversion | 2,887 | $0.00 | $0.00 | 40,479 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jan 30, 2026 | Exercise/Conversion | 2,000 | $0.00 | $0.00 | 42,479 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jan 30, 2026 | Exercise/Conversion | 3,750 | $0.00 | $0.00 | 46,229 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jan 30, 2026 | Exercise/Conversion | 2,859 | $0.00 | $0.00 | 49,088 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jan 30, 2026 | Sale | 3,588 | $16.58 | $59,498.37 | 45,500 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jan 30, 2026 | Sale | 73 | $17.37 | $1,268.13 | 45,427 | Direct | โ | View Details | |
Chief Financial Officer | Restricted Stock Units | Derivative | Jan 30, 2026 | Exercise/Conversion | 2,887 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Chief Financial Officer | Restricted Stock Units | Derivative | Jan 30, 2026 | Exercise/Conversion | 2,000 | $0.00 | $0.00 | 2,000 | Direct | โ | View Details | |
Chief Financial Officer | Restricted Stock Units | Derivative | Jan 30, 2026 | Exercise/Conversion | 3,750 | $0.00 | $0.00 | 18,750 | Direct | โ | View Details | |
Chief Financial Officer | Restricted Stock Units | Derivative | Jan 30, 2026 | Exercise/Conversion | 2,859 | $0.00 | $0.00 | 25,725 | Direct | โ | View Details |